Immunodiagnostic Systems Hldgs PLC Update on CEO Appointment (8371X)
February 24 2017 - 9:31AM
UK Regulatory
TIDMIDH
RNS Number : 8371X
Immunodiagnostic Systems Hldgs PLC
24 February 2017
Immunodiagnostic Systems Holdings PLC
24 February 2017
Update on CEO Appointment
Immunodiagnostic Systems Holdings plc ("IDS"), a specialist
producer of manual and automated diagnostic testing kits and
instruments for the clinical market today provides an update
following the announcement on 19 January 2017 that Patricio Lacalle
would be succeeded by Regis Duval as CEO.
IDS is pleased to confirm that Regis will join on 1 March
2017.
The following information is disclosed pursuant to Schedule Two
paragraph (g) of the AIM Rules for Companies:
Full name and age: Regis Jacques Duval (aged 45)
Current Directorships and Partnerships
N/A
Previous Directorships and Partnerships in last five years:
Bio-Rad spol. s.r.o.
Bio-Rad Magyarország Kft.
There are no other disclosures required in relation to Rule 17
or paragraph (g) of Schedule 2 of the AIM Rules for Companies.
For further information:
Immunodiagnostic Systems Tel : +44 (0)191
Holdings plc 519 0660
Patricio Lacalle, Chief
Executive Officer
Paul Martin, Group Finance
Director
Peel Hunt LLP Tel : +44 (0)207
418 8900
James Steel
Oliver Jackson
About Immunodiagnostic Systems Holdings PLC:
The Group's vision is to be a leading solution provider to the
clinical laboratory diagnostic market. IDS's strategy is focused on
developing, internally and through partnership, its automated assay
menu for its proprietary automated immunoassay analyser, the
IDS-iSYS system. Internally the Group is focused on developing an
endocrinology excellence menu and externally IDS works with
partners to develop assay panels in complementary indication
fields. The Group sells its products primarily in the clinical
laboratory market across a range of customers from reference
laboratories to physician office laboratories. IDS has field sales
forces in certain European countries, including France and Germany,
the United States and Brazil and works with distributors in other
markets including China, Italy and Spain.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAEZLFLDLFLBBZ
(END) Dow Jones Newswires
February 24, 2017 10:31 ET (15:31 GMT)
Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From Apr 2024 to May 2024
Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From May 2023 to May 2024